Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Shares Outstanding (Entity) of $310.5 million for Q1 2026, up 3.48% year-over-year from $300.0 million in Q1 2025, and up 2.83% quarter-over-quarter from $302.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Shares Outstanding (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $310.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 3.48% year-over-year to $310.5 million; the TTM figure through Mar 2026 stood at $310.5 million (up 3.48% YoY), while the FY2025 annual figure was $302.0 million, up 2.56% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $310.5 million, up from $302.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $310.5 million in Q1 2026, with the low at $224.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $272.3 million (2024), against an average of $268.0 million.
- Peak annual rise in Shares Outstanding (Entity) reached 1914.42% in 2022, while the deepest fall reached 2.5% in 2022.
- Pacific Biosciences Of California's Shares Outstanding (Entity) stood at $226.5 million in 2022, then advanced by 18.21% to $267.7 million in 2023, then advanced by 9.96% to $294.4 million in 2024, then rose by 2.56% to $302.0 million in 2025, then grew by 2.83% to $310.5 million in 2026.
- Business Quant data shows PACB's Shares Outstanding (Entity) at $310.5 million in Q1 2026, $302.0 million in Q4 2025, and $301.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 310.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 310.66 Mn |
| Mar 31, 2026 | 305.82 Mn |
| Dec 31, 2025 | 299.96 Mn |
| Sep 30, 2025 | 300.84 Mn |
| Jun 30, 2025 | 300.16 Mn |
| Mar 31, 2025 | 296.86 Mn |
| Dec 31, 2024 | 274.49 Mn |
| Sep 30, 2024 | 272.92 Mn |
| Jun 30, 2024 | 272.39 Mn |
| Mar 31, 2024 | 269.58 Mn |
| Dec 31, 2023 | 253.63 Mn |
| Sep 30, 2023 | 255.00 Mn |
| Jun 30, 2023 | 250.07 Mn |
| Mar 31, 2023 | 242.03 Mn |
| Dec 31, 2022 | 224.55 Mn |
| Sep 30, 2022 | 225.12 Mn |
| Jun 30, 2022 | 224.50 Mn |
| Mar 31, 2022 | 222.29 Mn |
| Dec 31, 2021 | 204.14 Mn |
| Sep 20, 2021 | 198.57 Mn |